BridgeMD
Compares treatment options for Palate; Wound
Official title Effect of Cyanoacrylate Tissue Adhesive Versus Collagen Sponge on Palatal Donor Site Healing
ClinicalTrials.gov ID: NCT07086482
What this study is testing
What is Cyanoacrylate tissue adhesive?
Cyanoacrylate tissue adhesive is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for palate; wound.
Also referred to as PeriAcryl.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if the use of cyanoacrylate glue (PeriAcryl) is effective in healing of the palatal donor site in adults requiring a free gingival graft. The main question(s) it aims to answer [is/are]: Does PeriAcryl accelerate the palatal tissue healing compared with the use of collagen sponge?
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Low-moderate anesthetic risk (ASA I-II)
- No restriction on ethnicity or gender
- Patients requiring FGG from the palate for periodontal plastic surgery
- Clinically healthy gingiva after phase I therapy
- Full-mouth plaque index grades 0 and 1
You likely can't join if
- Patients who smoke \> 10 cigarettes/day
- Patients with coagulation disorders
- Systemic diseases
- Patients on certain medications that may affect periodontal tissues
- Pregnant and lactating patient
- Patients with allergies to drugs that will be prescribed during the treatment phase
See the full eligibility criteria
- Low-moderate anesthetic risk (ASA I-II)
- No restriction on ethnicity or gender
- Patients requiring FGG from the palate for periodontal plastic surgery
- Clinically healthy gingiva after phase I therapy
- Full-mouth plaque index grades 0 and 1
- Bleeding scores \<15%
- Patients who smoke \> 10 cigarettes/day
- Patients with coagulation disorders
- Systemic diseases
- Patients on certain medications that may affect periodontal tissues
- Pregnant and lactating patient
- Patients with allergies to drugs that will be prescribed during the treatment phase
- Pathological mental conditions (dementia, psychosis) and lack of cooperation
- Excessive gag reflex
The study team makes the final eligibility decision.
Where it's taking place
- Beirut, Lebanon
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beirut, Lebanon. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.